急诊与择期指征的全膝关节翻修术死亡率和并发症差异
基于1997至2017年英国HES数据,939,021例初次膝关节置换中40,854例翻修、9,100例再翻修。择期翻修90天死亡率0.44%,与初次置换0.46%相当;感染翻修死亡率2.04%(OR 3.54),假体周围骨折翻修5.25%(OR 6.23),且肺栓塞、心梗、卒中发生率更高。
要点
- 择期翻修90天死亡率0.44%,与初次膝关节置换0.46%相当。
- 感染翻修90天死亡率2.04%,假体周围骨折翻修高达5.25%。
- 急诊指征翻修者肺栓塞、心梗、卒中发生率也更高。
核心结论
- 因感染或骨折等急诊指征行翻修术的患者,死亡率和严重不良事件风险高于初次置换和择期翻修。
研究设计与样本
- 基于英国国家医院统计(HES)1997年4月1日至2017年3月31日数据,纳入939,021例初次膝关节置换患者,识别后续40,854例翻修和9,100例再翻修,主要结局为90天死亡率。
主要发现
- 择期翻修90天死亡率为0.44%(135/30,826;95%CI 0.37-0.52),与初次置换0.46%(4,292/939,021;95%CI 0.44-0.47)相当。
- 感染翻修90天死亡率为2.04%(184/9,037;95%CI 1.75-2.35;OR 3.54;95%CI 2.81-4.46)。
- 假体周围骨折翻修90天死亡率为5.25%(52/991;95%CI 3.94-6.82;OR 6.23;95%CI 4.39-8.85)。
- 感染和骨折翻修队列中肺栓塞、心肌梗死和卒中发生率也更高。
关键数值与推荐
- 急诊指征定义为感染或骨折,其他指征(如松动、不稳、磨损)归为择期指征。
- 主要结局为90天死亡率,采用logistic回归分析相关因素及次要不良结局。
临床怎么用
- 急诊指征翻修术前应充分告知患者较高的死亡和严重并发症风险,用于知情同意和共享决策。
- 研究结果可为该患者群体的服务设计提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To compare rates of serious adverse events in patients undergoing revision knee arthroplasty with consideration of the indication for revision (urgent versus elective indications), and compare these with primary arthroplasty and re-revision arthroplasty. METHODS: Patients undergoing primary knee arthroplasty were identified in the national Hospital Episode Statistics (HES) between 1 April 1997 to 31 March 2017. Subsequent revision and re-revision arthroplasty procedures in the same patients and same knee were identified. The primary outcome was 90-day mortality and a logistic regression model was used to investigate factors associated with 90-day mortality and secondary adverse outcomes, including infection (undergoing surgery), pulmonary embolism, myocardial infarction, and stroke. Urgent indications for revision arthroplasty were defined as infection or fracture, and all other indications (e.g. loosening, instability, wear) were included in the elective indications cohort. RESULTS: A total of 939,021 primary knee arthroplasty procedures were included (939,021 patients), of which 40,854 underwent subsequent revision arthroplasty, and 9,100 underwent re-revision arthroplasty. Revision surgery for elective indications was associated with a 90-day rate of mortality of 0.44% (135/30,826; 95% confidence interval (CI) 0.37 to 0.52) which was comparable to primary knee arthroplasty (0.46%; 4,292/939,021; 95% CI 0.44 to 0.47). Revision arthroplasty for infection was associated with a much higher mortality of 2.04% (184/9037; 95% CI 1.75 to 2.35; odds ratio (OR) 3.54; 95% CI 2.81 to 4.46), as was revision for periprosthetic fracture at 5.25% (52/991; 95% CI 3.94 to 6.82; OR 6.23; 95% CI 4.39 to 8.85). Higher rates of pulmonary embolism, myocardial infarction, and stroke were also observed in the infection and fracture cohort. CONCLUSION: Patients undergoing revision arthroplasty for urgent indications (infection or fracture) are at higher risk of mortality and serious adverse events in comparison to primary knee arthroplasty and revision arthroplasty for elective indications. These findings will be important for patient consent and shared decision-making and should inform service design for this patient cohort. Cite this article: Bone Joint J 2021;103-B(10):1578-1585.
引用
- Abram SGF, Sabah SA, Alvand A, et al. Differences in mortality and complication rates following revision knee arthroplasty performed for urgent versus elective indications. Bone Joint J. 2021. PMID: 34587801. doi:10.1302/0301-620X.103B10.BJJ-2020-2590.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。